Company intelligence
Integrated DNA Technologies
Lab to life-changing advances. We’ll help.
About Integrated DNA Technologies
Building from a strong foundation of innovation, expertise, and reliability, Integrated DNA Technologies (IDT) has evolved from an oligo manufacturer to a leading genomics provider. We work shoulder-to-shoulder with scientific and global health partners to enable genomics breakthroughs at scale. Our vision of enabling researchers to rapidly move from the lab to life-changing advances reflects our ongoing commitment to a healthier, brighter future for all. IDT is proud to be part of Danaher. Danaher is a global life sciences and diagnostics innovator committed to accelerating the power of science and technology to improve human health. Together, we partner with customers to solve their toughest challenges—with speed and certainty. IDT Privacy Notice: https://idtb.io/privacy
Verified activity
Signals from Integrated DNA Technologies
18 published signals
Partnerships
Integrated DNA Technologies expanded its collaboration with Ansa Biotechnologies, Inc. to provide broader global access to long and complex synthetic DNA through a streamlined ordering experience, benefiting over 400 institutions across 33 countries.
Reported by Integrated DNA Technologies
Presence & Recognition
Integrated DNA Technologies celebrated its 10th anniversary
Reported by Marc Bleischwitz
Research & Knowledge
Integrated DNA Technologies published a study by Nature Communications highlighting the strongest sensitivity and precision delivered by their UNCOVERseq™ off-target analysis service across evaluated methods.
Reported by Silvia Herranz Fernandez
Research & Knowledge
Integrated DNA Technologies published recent research in Nature Communications demonstrating that IDT's UNCOVERseq™ achieved the strongest combined sensitivity and precision among the approaches evaluated.
Reported by Integrated DNA Technologies
Products & Services
Integrated DNA Technologies expanded its synthesis capabilities to help researchers access diversity, quality, and scale needed for the next generation of cancer research.
Reported by Silvia Herranz Fernandez
Presence & Recognition
Integrated DNA Technologies is attending the ECP2026 pathology and moleculardiagnostics community event at booth 323.
Reported by Integrated DNA Technologies
Presence & Recognition
Integrated DNA Technologies is attending the GEAR26 conference for the first time.
Reported by Integrated DNA Technologies
People
Integrated DNA Technologies celebrated its 10th anniversary.
Reported by Silvia Herranz Fernandez
Products & Services
Integrated DNA Technologies and Ansa provide a clearer path forward for mid-range DNA design, better continuity from fragments to genes, and support for increasing complexity.
Reported by Silvia Herranz Fernandez
Presence & Recognition
Integrated DNA Technologies celebrated its nearly four-decade anniversary.
Reported by Integrated DNA Technologies
Partnerships
Integrated DNA Technologies expanded its collaboration with Ansa Biotechnologies, Inc., providing broader global access to long and complex synthetic DNA through a streamlined ordering experience.
Reported by Integrated DNA Technologies
Products & Services
Integrated DNA Technologies developed UNCOVERseq™ to provide a more sensitive, reproducible, and standardized approach to off-target nomination for CRISPR-based therapies.
Reported by Silvia Herranz Fernandez
Presence & Recognition
Integrated DNA Technologies is attending the EMEA Advanced Genomics Symposium 2026 to discuss trends and scientific breakthroughs in genomics.
Reported by Juliette Gregoire
Products & Services
Integrated DNA Technologies expanded its DNASynthesis capabilities to produce low yield, high-diversity oligos and extend its high-yield, high-fidelity oligo production capabilities.
Reported by Sabine Le Gall
Research & Knowledge
Integrated DNA Technologies and Ansa Biotechnologies, Inc. collaboration is featured in a blog post expanding access to complex, sequence-verified DNA.
Reported by Integrated DNA Technologies
Presence & Recognition
Integrated DNA Technologies is exhibiting at booth 323 at ECP2026, where trusted experts will share information about their portfolio of blood cancer research solutions and Archer technologies.
Reported by Yan (Zhou) Tran
Research & Knowledge
Integrated DNA Technologies published a study by scientists highlighting the strength of their UNCOVERseq™ off-target analysis service across evaluated methods.
Reported by Jennifer DURANT-VESGA, PhD.🧬
Research & Knowledge
Integrated DNA Technologies delivered the strongest combination of sensitivity and precision among evaluated methods with its UNCOVERseq™
Reported by Marc Bleischwitz